Breaking News - The Fly

Open Search

APTO

Aptose Biosciences

$

()

Aptose Biosciences proceeds from closing of public offering Jan 30 $9.7M

APTO

3/26/2024 - 16:15pm

Aptose Biosciences reports FY23 EPS ($7.58) vs ($6.80) last yeat

APTO

3/26/2024 - 16:12pm

Aptose Biosciences price target lowered by $7 at Piper Sandler, here's why

APTO

2/1/2024 - 09:00am

Aptose Biosciences prices 4.9M shares at $1.71 in underwritten public offering

APTO

1/26/2024 - 08:08am

Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

KURA , JNJ , GRCL

…

12/14/2023 - 10:50am

Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

KURA , JNJ , GRCL

…

12/14/2023 - 05:55am

Aptose's tuspetinib clinical data featured in oral presentation at 2023 ASH

APTO

12/10/2023 - 06:55am

Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

KURA , JNJ , GRCL

…

12/7/2023 - 10:15am

Aptose Biosciences files to sell 4.1M shares of common stock, warrants

APTO

12/4/2023 - 06:10am

Aptose names Fletcher Payne chief business officer

APTO

11/30/2023 - 17:00pm

Aptose Biosciences price target lowered to $18 from $23 at RBC Capital

APTO

11/10/2023 - 08:51am

Aptose Biosciences reports Q3 EPS ($1.76), consensus ($2.05)

APTO

11/9/2023 - 16:04pm

Oppenheimer biotechnology analyst to hold an analyst/industry conference call

SNDX , KURA , VOR

…

11/9/2023 - 09:25am

Oppenheimer biotechnology analyst to hold an analyst/industry conference call

SNDX , KURA , VOR

…

11/9/2023 - 04:55am

Oppenheimer biotechnology analyst to hold an analyst/industry conference call

SNDX , KURA , VOR

…

11/2/2023 - 15:25pm